JPRN-UMIN000002620已完成3 期
Effect of human atrial natriuretic peptide for prevention of atrial fibrillation after CABG: a randomised controlled trial - NU-HIT trial for Af after CABG
ihon University school of medicine0 个研究点目标入组 700 人开始时间: 2009年10月12日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 700
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •past of arrhythmia cardiogenic shock NYHA class IV congestive heart failure despite treatment sinus bradycardia at rest (<50/min) second -or third-degree AV block clinical hypothyroidism or hyperthyroidism Doctor's decision not to register to this regimen
研究者
相似试验
已完成
不适用
Phase 1 study of human atrial natriuretic peptide during perioperative period for completely resected colorectal cancerColorectal cancerJPRN-UMIN000025877Osaka University Graduate School of Medicine5
已完成
不适用
Efficacy of human atrial natriuretic peptide for the patients with severe sepsis; Impact on prevention against acute kidney injurySevere sepsisJPRN-UMIN000003821Tosei General Hospital60
已完成
2 期
Human atrial natriuretic peptide during perioperative period for completely resected non-small cell lung cancer: a multicentre, open-label, randomised controlled trialnon-small cell lung cancerJPRN-UMIN000018480ational Cerebral and Cardiovascular Center332
进行中（未招募）
1 期
A prospective evaluation of natriuretic peptide based referral of chronic heart failure patients in primary careEUCTR2016-000473-20-HRovartis Pharma services AG1,415
已完成
不适用
ow dose atrial natriuretic peptide provides effective renal protection from acute kidney injury after aortic arch surgery: a randomised controlled trialacute kidney injuryJPRN-UMIN000011650Kawasaki Saiwai Hospital43